Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,832 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07300969RecruitingPhase 2
Testing DT-101 for adults with depression
This trial tests a new medicine called DT-101 to see if it helps people with depression. It is for adults who have had more than one depressive episode in their life.
Bentonville, ArkansasAges 18–75 - NCT07457580Recruiting
A real-world study of teplizumab for type 1 diabetes
This study looks at real-world outcomes in patients with type 1 diabetes who received teplizumab through managed access programs. It helps researchers understand how well the treatment works outside of a clinical trial setting.
LeuvenAges Any age - NCT07435662Recruiting
Improving heart failure care in Denver
This study aims to improve heart failure treatment for people who have limited access to care in Denver. If you have heart failure with reduced pumping ability and are a patient in the Denver Health system, this trial may help find better ways to manage your condition.
Denver, ColoradoAges 18 years+ - NCT07383506RecruitingPhase 1
Study of a targeted pill for PIK3CA-mutated advanced cancers
This trial tests a new pill (CGT6297) that targets cancer cells with a specific PIK3CA gene change. It may be an option for people with certain advanced solid tumors, including endometrial or breast cancer, after standard treatments have stopped working.
Scottsdale, ArizonaAges 18 years+ - NCT07532174Recruiting
Blood-Cleaning Device During Heart Surgery
This trial tests a special blood-filtering device (Efferon LPS) used during heart surgery to reduce inflammation and improve recovery. The device removes harmful substances from your blood during the operation.
BarnaulAges 18 years+ - NCT07730190RecruitingPhase 1
Testing TQB6426 for advanced solid tumors
This trial tests a new drug called TQB6426 for people with advanced solid tumors that have not responded to other treatments. The drug targets a protein called GPC3 found on some tumors, aiming to deliver a powerful therapy directly to the cancer cells.
Hefei, AnhuiAges 18–75 - NCT07347990Recruiting
Iptacopan for high-risk TA-TMA after stem cell transplant
This trial tests a new oral medicine called iptacopan for people who have a serious blood vessel complication after a stem cell transplant (TA-TMA) that is not improving with usual treatments. The goal is to see if iptacopan can help stop the damage and improve recovery.
Hangzhou, ChinaAges 12 years+ - NCT07180121Enrolling by invitation
Information and support needs after bladder cancer surgery
This study looks at the information and support needs of people who have had bladder cancer and undergone a cystectomy. It aims to see how these needs change over time and to improve supportive care after surgery.
LinköpingAges 18–100 - NCT06893276Recruiting
Wellness program for pancreatic cancer
This study tests an online wellness program that helps people with pancreatic cancer manage stress and symptoms. The program is available in English and Spanish and is designed to improve your quality of life during treatment.
Miami, FloridaAges 18 years+ - NCT06717958RecruitingPhase 2
Ivosidenib after stem cell transplant for IDH1-mutated AML or MDS
This trial tests whether taking ivosidenib after a stem cell transplant can help prevent leukemia from coming back in people with a specific gene change called IDH1. It may be an option if you have AML or MDS with that mutation and are recovering from transplant.
AachenAges 18–75 - NCT06607939RecruitingPhase 1
Study of ORB-021 for advanced solid tumors
This trial tests a new drug called ORB-021 for people with advanced solid tumors that have come back or not responded to other treatments. The goal is to see if ORB-021 is safe and how it affects the body.
Scottsdale, ArizonaAges 18 years+ - NCT06376760Recruiting
Anesthetic dose changes for insomnia patients during endoscopy
This study looks at how insomnia affects the amount of anesthesia needed during a digestive endoscopy. It compares people with insomnia to those with normal sleep to see if dosage adjustments are needed.
Beijing, Beijing MunicipalityAges 18–64 - NCT06984484Recruiting
Afluxin for GERD: safety and performance study
This trial tests a new treatment called Afluxin for people with gastroesophageal reflux disease (GERD), which causes heartburn and regurgitation. It aims to see if Afluxin is safe and works better than a placebo (inactive control) to relieve symptoms.
GenovaAges 18–75 - NCT07576036Enrolling by invitation
Study of severe low sodium and brain safety during treatment
This is a retrospective study (meaning researchers look back at medical records) of patients who had very low sodium levels in their blood when admitted to the hospital. Researchers want to understand the link between how quickly doctors correct low sodium and a rare brain condition called osmotic demyelination syndrome.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07109817RecruitingPhase 2
Desloratadine to prevent nerve damage from taxane chemo in breast cancer
This trial tests if the allergy medicine desloratadine can prevent nerve damage (numbness, tingling, pain) caused by taxane chemotherapy in people with early-stage breast cancer. Taking desloratadine daily during chemo may help protect your nerves.
The Bronx, New YorkAges 18 years+ - NCT07788144Enrolling by invitation
Blood-cleaning therapy for severe belly infections
This study tests a blood-cleaning treatment to remove harmful toxins from the blood of people with severe abdominal infections. It might help their organs recover faster.
SeoulAges 18 years+ - NCT07141524Enrolling by invitation
Breathing and blood flow optimization during heart-lung machine support
This study looks at ways to improve breathing and blood flow in patients who are on a heart-lung machine (ECMO) for severe heart problems. It may help doctors better manage care for people in intensive care.
Boston, MassachusettsAges 18 years+ - NCT06981936RecruitingPhase 4
Do vitamins help prevent deficiencies while on weight-loss injections?
This trial tests if a daily multivitamin and mineral tablet can prevent nutrient shortages in people taking GLP-1 medicines (like Wegovy or Saxenda) for weight loss. You would take either the vitamin tablet or a placebo (a tablet with no active ingredients) for a year, to see which group has better nutrient levels.
AlexandriaAges 18–65 - NCT06977555Enrolling by invitation
Talking with ICU patients on a breathing machine
This study looks at how nurses and doctors communicate with patients who are awake but on a breathing machine (ventilator) in the intensive care unit (ICU). The goal is to improve communication and make the experience better for patients.
OsloAges 18 years+ - NCT06959771RecruitingPhase 1/Phase 2
Gene therapy for CD40L deficiency (Hyper-IgM syndrome) - single patient study
This trial tests a new gene therapy that uses a person's own blood stem cells and T cells, which are corrected with a gene-editing tool called base editing. It is designed for people with a specific CD40L gene mutation who also have liver problems and portal hypertension. The goal is to see if this treatment can improve their immune system and liver health.
Bethesda, MarylandAges 37–120 - NCT06952608RecruitingPhase 4
Ciprofol for blood pressure stability in older adults on heart medications
This study tests whether ciprofol, a newer sedative, can help prevent low blood pressure during surgery in older patients who are already taking medications for high blood pressure or heart failure (called RAS inhibitors). It may be a good option if you're 65 or older, on these medications for more than 3 months, and having abdominal surgery lasting over 2 hours.
Hangzhou, ZhejiangAges 65 years+ - NCT06923462Recruiting
VoiceLove app for ICU patients on a ventilator
This study tests a special app called VoiceLove that helps patients in the ICU who are on a breathing machine communicate with their family and care team. The goal is to reduce confusion and improve connection and satisfaction for everyone involved.
Nashville, TennesseeAges 18 years+ - NCT06885073Recruiting
A new way to check vein pressure in children without needles
This trial tests a new way to measure pressure inside a major vein in the chest without needing to stick any needles. It might be an option for children and young adults up to age 21 who already have a central line or are getting a heart catheter.
Washington D.C., District of ColumbiaAges Up to 21 years - NCT06781619Recruiting
Plant-based drink study for people at risk of malnutrition
This study tests a plant-based, high-energy, high-protein drink for people who are at medium or high risk of malnutrition. You would replace your current prescribed supplement with either a plant-based or dairy-based drink for 8 weeks to see how it affects your nutrition.
MechelenAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,832 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.